Security | Threat Detection | Cyberattacks | DevSecOps | Compliance

What Are White Label Cloud Services? White-label cloud services are cloud solutions that are provided by a third-party vendor but can be rebranded and customized to fit the branding and requirements of the MSP or their clients. Essentially, white-label cloud services allow MSPs to offer cloud-based solutions under their own brand, enabling them to maintain consistency in their service offerings and provide a more cohesive experience to their clients.

Broken access control, the vulnerability category consistently ranking on the OWASP Top 10 Web Application Security Risks list, poses the most significant challenge for application security right now. Over-reliance on automated solutions to tackle these challenges creates a false sense of security and could have severe implications for application owners.

Single sign-on (SSO) is a tool that simplifies the authentication process by allowing users to log in and access various digital applications and services using a single set of credentials. This authentication solution works through a central service that authenticates users once and then provides an authentication token for the applications they wish to use. This token enables applications to verify user identity without users having to re-enter their credentials.

In today’s digital world, the importance of cybersecurity is more critical than ever. With the constant evolution of cyber threats, safeguarding sensitive data and digital assets has transitioned from an option – to an absolute necessity. Each October, Cybersecurity Awareness Month focuses on the importance of cybersecurity in our interconnected world.

The timeline of an application can be broadly described in 3 phases: Thus, runtime security in the context of a cloud-native container environment broadly refers to the tools and processes leveraged to protect the operation of running containers in production.

Fines and penalties for regulatory noncompliance within biopharma have been well documented. Since 2000, violations for noncompliance have cost biopharma $50B—and the costs of addressing root causes of noncompliance have grown as well, climbing by more than 40% since 2011 according to some estimates. The costs of remediating a deficiency can vary considerably, from as little as $250K to $5M for a Form 483 cited deficiency.